Stroke
Conditions
Interventions
Sponsors
Huashan Hospital Affiliated to Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Inclusion criteria for stroke: (1) Patients with unilateral cerebral hemorrhage or cerebral infarction were confirmed by CT or MRI; (2) The duration of stroke was more than 2 weeks; (3) The subjects who were 18 years old or less and 80 years old or less were not limited to men and women, left and right handedness; (4) The tension of biceps brachii and flexor carpi of the affected upper limb was less than or equal to grade 2 (modified Ashworth scale); The muscle strength of affected wrist was 0-4 (MMT standard Lovett classification); The motor function of the contralateral upper limb was good; (5) There was no obvious discomfort in the process of body position change (the subjects were transferred from bed to wheelchair with the help of two people), blood pressure, heart rate, breathing were stable, no pain, chest tightness, shortness of breath, dizziness, headache and other discomfort, and they could tolerate sitting for 30 minutes; (6) The subjects without cognitive impairment (secondary school or above: MMES >= 24, primary school: MMES >= 20, illiterate: MMES >= 17) can cooperate with the treatment and evaluation; (7) Subjects who signed informed consent. 2. Inclusion criteria for non disease subjects: (1) The subjects aged 18 years = 24, primary school: MMES >= 20, illiterate: MMES >= 17) can cooperate with the assessment; (4) Subjects who signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with other central nervous system diseases in the past; 2. Patients with contraindications of neuroelectrophysiology and low-frequency electrical stimulation therapy: epidermis damage, fever, tumor history, pacemaker wearing, intracranial metal implants and other metal implants in vivo or skull defects, epilepsy, pregnancy, lactation, or women of childbearing age without reliable contraceptive measures, etc; 3. Patients with severe systemic diseases who cannot participate in the study: Patients with severe respiratory, heart, liver, kidney, endocrine and hematopoietic system diseases, such as congestive heart failure, arrhythmia and uncontrolled hypertension; 4. Patients with obvious limb deformity or other diseases affecting upper limb movement: severe upper limb infection, contracture, joint operation, amputation, fracture, rheumatism or rheumatoid arthritis; 5. Patients with severe cognitive, speech, vision, hearing impairment (such as deaf mute) or mental disorders that affect the examination and treatment; 6. Patients who recently participated in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The change of HbO in ROI; | — |
Countries
China
Contacts
Public ContactBai Yulong
Huashan Hospital Affiliated to Fudan University
Outcome results
None listed